{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:50:15Z","timestamp":1793155815533,"version":"4.5.0"},"reference-count":131,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Discovery"],"published-print":{"date-parts":[[2021,12,2]]},"DOI":"10.1080\/17460441.2021.1948833","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T21:40:11Z","timestamp":1625089211000},"page":"1517-1535","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":67,"title":["Retinoic acid-related orphan receptor gamma t (ROR\u03b3t) inverse agonists\/antagonists for the treatment of inflammatory diseases \u2013 where are we presently?"],"prefix":"10.1080","volume":"16","author":[{"given":"Christian","family":"Gege","sequence":"first","affiliation":[{"name":"Immunic AG","place":["Gr\u00e4felfing, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2011.12.011"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1530\/JME-13-0212"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010919-023711"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.07.035"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3742"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2017.1363884"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.07.004"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm401901d"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.109.060905"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10075"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2014.120"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2016.08.012"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2017.1236918"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00588"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2019.1655541"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10202-7"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1039\/D0NP00047G"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2017.1262350"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2016.1153066"},{"key":"e_1_3_5_22_1","unstructured":"Narjes F. The discovery of AZD0284 an inverse agonist of the nuclear receptor ROR\u03b3. Drug Design and Delivery Symposium Oct 26 2017; American Chemical Society: Washington DC. \u00a0[cited 2017\u00a0Oct\u00a026]. Available from: www.acs.org\/content\/acs\/en\/acs-webinars\/drug-discovery\/psoriasis.html"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201700278"},{"key":"e_1_3_5_24_1","unstructured":"Vitae Pharmaceuticals 8-K - Current report published: 2016-Mar-16. \u00a0[cited 2021\u00a0Mar\u00a015]. Available from: https:\/\/sec.report\/Document\/0001104659-16-105501\/"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.125528"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147979"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16131"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2013.12.021"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2014.09.053"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.5b00122"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.91127"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302190"},{"key":"e_1_3_5_33_1","unstructured":"Exelixis 2010 Annual Report \u00a0[cited 2021\u00a0May\u00a02]. Available from: https:\/\/ir.exelixis.com\/annual-reports"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1867"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.12.006"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127174"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127205"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.9b00010"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127441"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01369"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2019.06.036"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.0c00063"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127466"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127521"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.0c00496"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127204"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127392"},{"key":"e_1_3_5_48_1","volume-title":"Society of Toxicology (SOT) 59th Annual Meeting and Tox Expo 2020, Anaheim, California, USA","author":"Haggerty HG","unstructured":"Haggerty HG, Sathish J, Gleason C, et al. Thymic lymphomas in a 6-month CByB6F1\/Tg rasH2 carcinogenicity study with a ROR\u03b3t inverse agonist, BMS-986251. Society of Toxicology (SOT) 59th Annual Meeting and Tox Expo 2020, Anaheim, California, USA. Poster #1121. [cited 2021 Feb 2]. Available from: www.criver.com\/59th-annual-society-toxicology-meeting-and-toxexpo"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw1736"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01992"},{"key":"e_1_3_5_51_1","unstructured":"Development of antagonists to ROR-gamma. [cited 2021\u00a0May\u00a02]. Available from: www.orphagen.com\/autoimmune-disease\/"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.0c00575"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.5b00253"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/gtc.12494"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35783-9"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01567"},{"key":"e_1_3_5_57_1","unstructured":"Pharmaceutical business clinical development as of February 9 2021. \u00a0[cited 2021\u00a0May\u00a02]. Available from: jt.com\/investors\/results\/presentation_financial\/index.html."},{"key":"e_1_3_5_58_1","unstructured":"Akos Pharmaceuticals pipeline. \u00a0[cited 2021\u00a0May\u00a02]. Available from: www.akrospharma.com\/pipeline-products\/pipe\/"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2017.12.039"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201900416"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2017.12.006"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2017.12.008"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00061"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.577016"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2018.01.023"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1159\/000492226"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-018-0875-7"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-019-01234-y"},{"key":"e_1_3_5_69_1","unstructured":"Takeda FY2016 Q4 results databook May 2017. [cited 2021\u00a0Feb\u00a013].Available from: www.takeda.com\/investors\/financial-results\/2016\/"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01181"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201500432"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00783"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.9b00158"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14253"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00392"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01545"},{"key":"e_1_3_5_77_1","unstructured":"The granted US patents US9920054 US10426135 claim solely these structure and also the prosecution of WO2016\/046755 in Europe named this structure as preferred compound in intented claim 21 (now withdrawn)."},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14412"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2019.05.015"},{"key":"e_1_3_5_80_1","unstructured":"Second patent application WO2016\/198908 covers less but the same compounds claiming only one priority application."},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.258046"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53240-z"},{"key":"e_1_3_5_83_1","unstructured":"ABBV-553: the depicted formula in Fig. 4B for ABBV-553 was one of four preferred structures in EP3307734B and application US2019\/0055196 was the continuation of US10106501 (many structures granted) which has now been abandoned."},{"key":"e_1_3_5_84_1","unstructured":"AbbVie (ABBV) Q1 2021 earnings call transcript. [cited 2021\u00a0May\u00a03]. Available from: www.fool.com\/earnings\/call-transcripts\/2021\/04\/30\/abbvie-abbv-q1-2021-earnings-call-transcript\/"},{"issue":"16","key":"e_1_3_5_85_1","first-page":"99","article-title":"Discovery of ARN-6039 as a potent, orally available inverse agonist of ROR\u03b3t for autoimmune neuroinflammatory demyelinating disease","volume":"86","author":"Rose J","year":"2016","unstructured":"Rose J, Carlson N, Yerramreddy V, et al. Discovery of ARN-6039 as a potent, orally available inverse agonist of ROR\u03b3t for autoimmune neuroinflammatory demyelinating disease. Neurology. 2016;86(16 Supplement):99.","journal-title":"Neurology"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1021\/cb200496y"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38272"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.126967"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9833"},{"issue":"1","key":"e_1_3_5_90_1","article-title":"RTA 1701 is an orally-bioavailable, potent, and selective ROR\u03b3t inhibitor that suppresses Th17 differentiation in vitro and is efficacious in mouse models of autoimmune disease","volume":"200","author":"Dulubova I","year":"2018","unstructured":"Dulubova I, Jian X, Trevino I, et al. RTA 1701 is an orally-bioavailable, potent, and selective ROR\u03b3t inhibitor that suppresses Th17 differentiation in vitro and is efficacious in mouse models of autoimmune disease. J Immunol. 2018;200(1 suppl):121.14.","journal-title":"J Immunol"},{"issue":"1","key":"e_1_3_5_91_1","article-title":"RTA 1701 is an oral ROR\u03b3t inhibitor that suppresses the IL-17A response in non-human primates","volume":"200","author":"Reisman SA","year":"2018","unstructured":"Reisman SA, Lee CY, Proksch JW, et al. RTA 1701 is an oral ROR\u03b3t inhibitor that suppresses the IL-17A response in non-human primates. J Immunol. 2018;200(1 suppl):175.22.","journal-title":"J Immunol"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2019.04.021"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep37977"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.02.044"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.10.027"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2018.03.093"},{"key":"e_1_3_5_97_1","unstructured":"Phenex AG announces milestone payment from Janssen for the entry of RORgt inhibitor into Phase I. [cited 2021\u00a0Feb\u00a018]. Available from: www.phenex-pharma.com\/phenex-ag-announces-milestone-payment-from-janssen-for-the-entry-of-rorgt-inhibitor-into-phase-i\/"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02307"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07911-6"},{"key":"e_1_3_5_100_1","volume-title":"Presentation at the 244th ACS National Meeting","author":"Tasler S.","unstructured":"Tasler S. Small molecule inhibitors of IL-17A and IL-17F for the treatment of autoimmune diseases. Presentation at the 244th ACS National Meeting, Philadelphia, August 19th, 2012."},{"key":"e_1_3_5_101_1","unstructured":"Kohlhof H Hietel B Schenk M et al. IMU-935: orally available small molecule inhibitor of IL-17 with unique molecular profile for the treatment of autoimmune diseases. CMMI 2019 Trondheim Norway 2019 June 3-6. [cited 2021\u00a0Jan\u00a021]. Available from: www.immunic-therapeutics.com\/imu935\/"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2008.06.092"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.11.073"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.9b00431"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.013581"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.09.048"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2015.05.055"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2015.1065816"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2016.10.023"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2021287118"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.0c00941"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01372"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103077"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.09.023"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155329"},{"key":"e_1_3_5_116_1","doi-asserted-by":"crossref","unstructured":"Hornberg JJ Laursen M Brenden N et al. Exploratory toxicology as an integrated part of drug discovery. Part I: why and how. Drug Discov Today. 2014;19:1131\u20131136.","DOI":"10.1016\/j.drudis.2013.12.008"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2013.12.009"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12582"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201700758"},{"key":"e_1_3_5_120_1","unstructured":"[cited 2021 Feb 28]. Available from: http:\/\/www.glenmarkpharma.com\/content\/rd-pipeline"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2020.1745773"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00184-7"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00125-2"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0302-0"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2016.01.001"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.211"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5475.2369"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3832"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2015.07.068"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01621"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319104"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4070"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2016.1086751"}],"container-title":["Expert Opinion on Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17460441.2021.1948833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T15:21:17Z","timestamp":1770391277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17460441.2021.1948833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":131,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,2]]}},"alternative-id":["10.1080\/17460441.2021.1948833"],"URL":"https:\/\/doi.org\/10.1080\/17460441.2021.1948833","relation":{},"ISSN":["1746-0441","1746-045X"],"issn-type":[{"value":"1746-0441","type":"print"},{"value":"1746-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-03-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}